【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 13
2 Introduction 14
2.1 Infectious Diagnostics Rapid & Point of Care Tests Overview 14
3 Products under Development 15
3.1 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Stage of Development 15
3.2 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Segment 16
3.3 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Territory 17
3.4 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Regulatory Path 19
3.5 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Estimated Approval Date 20
4 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products under Development by Companies 21
4.1 Infectious Diagnostics Rapid & Point of Care Tests Companies – Pipeline Products by Stage of Development 21
4.2 Infectious Diagnostics Rapid & Point of Care Tests – Pipeline Products by Stage of Development 24
5 Infectious Diagnostics Rapid & Point of Care Tests Companies and Product Overview 29
5.1 A&B Professional di Barsali Brunella Company Overview 29
5.1.1 A&B Professional di Barsali Brunella Pipeline Products & Ongoing Clinical Trials Overview 29
5.2 Akers Biosciences, Inc. Company Overview 30
5.2.1 Akers Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 30
5.3 Analyticon Biotechnologies AG Company Overview 34
5.3.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview 34
5.4 Aseptika Ltd Company Overview 36
5.4.1 Aseptika Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.5 Atomo Diagnostics Pty Limited Company Overview 37
5.5.1 Atomo Diagnostics Pty Limited Pipeline Products & Ongoing Clinical Trials Overview 37
5.6 Autoimmune Technologies, LLC Company Overview 39
5.6.1 Autoimmune Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 39
5.7 BACTERIOSCAN LTD. Company Overview 40
5.7.1 BACTERIOSCAN LTD. Pipeline Products & Ongoing Clinical Trials Overview 40
5.8 Biocartis SA Company Overview 41
5.8.1 Biocartis SA Pipeline Products & Ongoing Clinical Trials Overview 41
5.9 BioFire Diagnostics, Inc. Company Overview 42
5.9.1 BioFire Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.10 Biotech Consortium India Limited Company Overview 43
5.10.1 Biotech Consortium India Limited Pipeline Products & Ongoing Clinical Trials Overview 43
5.11 Calypte Biomedical Corporation Company Overview 47
5.11.1 Calypte Biomedical Corporation Pipeline Products & Ongoing Clinical Trials Overview 47
5.12 Canon U.S.A., Inc. Company Overview 50
5.12.1 Canon U.S.A., Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
5.13 Cepheid Company Overview 51
5.13.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 51
5.14 Coris BioConcept Company Overview 63
5.14.1 Coris BioConcept Pipeline Products & Ongoing Clinical Trials Overview 63
5.15 Denka Seiken Co., Ltd. Company Overview 64
5.15.1 Denka Seiken Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
5.16 Diagnostics for the Real World (Europe) Ltd. Company Overview 65
5.16.1 Diagnostics for the Real World (Europe) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 65
5.17 DIESSE Diagnostica Senese S.p.A. Company Overview 66
5.17.1 DIESSE Diagnostica Senese S.p.A. Pipeline Products & Ongoing Clinical Trials Overview 66
5.18 First Light Biosciences, Inc. Company Overview 67
5.18.1 First Light Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.19 Foundation for Innovative New Diagnostics Company Overview 68
5.19.1 Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 68
5.20 Genalyte, Inc. Company Overview 76
5.20.1 Genalyte, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
5.21 GeneFluidics Inc. Company Overview 77
5.21.1 GeneFluidics Inc. Pipeline Products & Ongoing Clinical Trials Overview 77
5.22 Great Basin Corporation Company Overview 79
5.22.1 Great Basin Corporation Pipeline Products & Ongoing Clinical Trials Overview 79
5.23 Hema Diagnostic Systems, LLC Company Overview 80
5.23.1 Hema Diagnostic Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 80
5.24 Immunexpress Pty Ltd Company Overview 81
5.24.1 Immunexpress Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 81
5.25 ImmunoScience, Inc. Company Overview 82
5.25.1 ImmunoScience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 82
5.26 InBios International, Inc. Company Overview 88
5.26.1 InBios International, Inc. Pipeline Products & Ongoing Clinical Trials Overview 88
5.27 Infectious Disease Research Institute Company Overview 91
5.27.1 Infectious Disease Research Institute Pipeline Products & Ongoing Clinical Trials Overview 91
5.28 Innova Biotechnology Co., Ltd. Company Overview 92
5.28.1 Innova Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 92
5.29 Insilixa, Inc. Company Overview 96
5.29.1 Insilixa, Inc. Pipeline Products & Ongoing Clinical Trials Overview 96
5.30 Institut de Recherche pour le Developpement Company Overview 98
5.30.1 Institut de Recherche pour le Developpement Pipeline Products & Ongoing Clinical Trials Overview 98
5.31 Institut Pasteur Company Overview 101
5.31.1 Institut Pasteur Pipeline Products & Ongoing Clinical Trials Overview 101
5.32 Integrated DNA Technologies, Inc. Company Overview 102
5.32.1 Integrated DNA Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 102
5.33 James Cook University Company Overview 103
5.33.1 James Cook University Pipeline Products & Ongoing Clinical Trials Overview 103
5.34 Labsystems Diagnostics Oy Company Overview 104
5.34.1 Labsystems Diagnostics Oy Pipeline Products & Ongoing Clinical Trials Overview 104
5.35 Leiden University Company Overview 107
5.35.1 Leiden University Pipeline Products & Ongoing Clinical Trials Overview 107
5.36 Life Technologies Corporation Company Overview 108
5.36.1 Life Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 108
5.37 Lucigen Corporation Company Overview 109
5.37.1 Lucigen Corporation Pipeline Products & Ongoing Clinical Trials Overview 109
5.38 Meru University of Science & Technology Company Overview 110
5.38.1 Meru University of Science & Technology Pipeline Products & Ongoing Clinical Trials Overview 110
5.39 Micronics, Inc. (of Sony Group) Company Overview 111
5.39.1 Micronics, Inc. (of Sony Group) Pipeline Products & Ongoing Clinical Trials Overview 111
5.40 NexGen Arrays Company Overview 116
5.40.1 NexGen Arrays Pipeline Products & Ongoing Clinical Trials Overview 116
5.41 NOWDiagnostics Company Overview 117
5.41.1 NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview 117
5.42 OptiCul Diagnostics Ltd. Company Overview 132
5.42.1 OptiCul Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 132
5.43 PrimerDesign Limited Company Overview 133
5.43.1 PrimerDesign Limited Pipeline Products & Ongoing Clinical Trials Overview 133
5.44 Protein Advances Inc. Company Overview 134
5.44.1 Protein Advances Inc. Pipeline Products & Ongoing Clinical Trials Overview 134
5.45 Quidel Corporation Company Overview 136
5.45.1 Quidel Corporation Pipeline Products & Ongoing Clinical Trials Overview 136
5.46 Quotient Limited Company Overview 140
5.46.1 Quotient Limited Pipeline Products & Ongoing Clinical Trials Overview 140
5.47 Randox Laboratories Limited Company Overview 142
5.47.1 Randox Laboratories Limited Pipeline Products & Ongoing Clinical Trials Overview 142
5.48 Rockefeller University Company Overview 143
5.48.1 Rockefeller University Pipeline Products & Ongoing Clinical Trials Overview 143
5.49 Sedia Biosciences Corporation Company Overview 144
5.49.1 Sedia Biosciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 144
5.50 Sight Diagnostics Ltd. Company Overview 145
5.50.1 Sight Diagnostics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 145
5.51 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 146
5.51.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 146
5.52 Standard Diagnostics, Inc. Company Overview 147
5.52.1 Standard Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 147
5.53 The Johns Hopkins University Company Overview 149
5.53.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 149
5.54 U.S. Army Medical Research Institute of Infectious Diseases Company Overview 151
5.54.1 U.S. Army Medical Research Institute of Infectious Diseases Pipeline Products & Ongoing Clinical Trials Overview 151
5.55 University of California, Berkeley Company Overview 152
5.55.1 University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview 152
5.56 University of California, Irvine Company Overview 154
5.56.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 154
5.57 University of Edinburgh Company Overview 156
5.57.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 156
5.58 University of Nevada, Reno Company Overview 157
5.58.1 University of Nevada, Reno Pipeline Products & Ongoing Clinical Trials Overview 157
5.59 University of Oxford Company Overview 163
5.59.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 163
5.60 University of Virginia Company Overview 164
5.60.1 University of Virginia Pipeline Products & Ongoing Clinical Trials Overview 164
5.61 Vircell S.L Company Overview 165
5.61.1 Vircell S.L Pipeline Products & Ongoing Clinical Trials Overview 165
5.62 Wholehealth Products, Inc. Company Overview 170
5.62.1 Wholehealth Products, Inc. Pipeline Products & Ongoing Clinical Trials Overview 170
5.63 Yale University Company Overview 171
5.63.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 171
5.64 Yeda Research and Development Company Ltd. Company Overview 172
5.64.1 Yeda Research and Development Company Ltd. Pipeline Products & Ongoing Clinical Trials Overview 172
6 Infectious Diagnostics Rapid & Point of Care Tests- Recent Developments 174
7 Appendix 210
7.1 Methodology 210
7.2 About GlobalData 212
7.3 Contact Us 213
7.4 Disclaimer 213
【レポート販売概要】
■ タイトル：世界における感染症迅速/POC検査製品のパイプライン動向2015■ 英文：Infectious Diagnostics Rapid & Point of Care Tests - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0084EPD
■ 調査対象地域：グローバル
- 医療レポート：Gram-Negative Bacterial Urinary Tract Infection-疫学予測（～2022）EpiCast Report: Gram-Negative Bacterial Urinary Tract Infection - Epidemiology Forecast to 2022 Summary Urinary tract infections (UTIs) are among the most common bacterial infections acquired in hospitals and in the community setting. A UTI can occur when daily living activities and medical interventions aid in the movement of bacteria into the urethra; however, bacterial colonization does not alw …
- 医薬品添加物の世界市場：リン酸カルシウム、炭酸カルシウム、硫酸カルシウム、岩塩、金属酸化物、糖質、グリコール、ポビドン、鉱物系炭化水素等Pharmaceutical excipients are inactive ingredients used along with the active ingredients in a drug formulation. While excipients may have different functionalities, they generally do not affect the therapeutic action of the active ingredient. The demand for functional excipients is expected to record a strong growth in the forecast period due to its increased use in advanced drug delivery forms. …
- 世界の医療産業におけるビックデータ支出市場About big data in healthcare Big data in the healthcare industry refers to a large and complex electronic health data that is difficult to manage with conventional software or hardware or data management tools. Big data in the healthcare industry is tremendous because of its volume, variety, and velocity required to manage it. This includes a wide variety of data ranging from patient data in elect …
- 世界のクラウド・セキュリティー・ソフトウェア市場動向（2012-2016）TechNavio's analysts forecast the Global Cloud Security Software market to grow at a CAGR of 49.4 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing usage of cloud services for critical data storage. The Global Cloud Security Software market has also been witnessing an increasing number of partnerships between cloud service providers and …
- Dental Implants Market to 2018 – Technical Advances and Procedure Efficiency Accelerate the Shift Away from Traditional DevicesDental Implants Market to 2018 - Technical Advances and Procedure Efficiency Accelerate the Shift Away from Traditional Devices Summary GBI Research's report, "Dental Implants Market to 2018 - Technical Advances and Procedure Efficiency Accelerate the Shift Away from Traditional Devices" provides key data, information and analysis for the global dental implants market. It examines the market and c …
- 世界のAPETフィルム市場2015Global APET Film Industry Report 2015 is a professional and in-depth study on the current state of the APET Film industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The APET Film market analysis is provided for the China markets including development trends, competitive landscape analysis, and key regions …
- アメリカのLBS（位置情報サービス）市場2016-2020About LBS Market in US LBS use the location of a mobile device to provide the required information through a mobile network. GPS deliver location information worldwide for outdoor environments. However, it does not provide such information for indoor environments. Technologies such as wireless fidelity (Wi-Fi), wireless local area network (WLAN) modems, radio frequency identification (RFID) tags, …
- 当座預金口座（Current Account）のグローバル市場：新トレンド、商品インサイト、事例分析Due to changes in regulatory frameworks and competitive dynamics, retail banking and its current account business have changed gradually during the last decade. Despite initiatives taken by banks to retain customers, the current accounts market in developed economies recorded growing instances of account switching. Improved customer service, attractive reward programs and financial incentives offe …
- 建物・建設産業向けナノコーティング剤の世界市場2017-2021About nanocoatings Nanocoatings coat surfaces with nanostructures that form a uniform network of molecules. The thickness of these coatings is measured in nanoscales. Technavio’s analysts forecast the global nanocoatings market for the building and construction industry to grow at a CAGR of 20.41% during the period 2017-2021. [Covered in this report] The report covers the present scenario and the …
- 世界の政府におけるスマートカード市場（2012-2016）TechNavio's analysts forecast the Global Smart Cards market in the Government sector to grow at a CAGR of 6.48 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need for a tamper-free system. The Global Smart Cards market in the Government sector has also been witnessing the increasing use of contactless ID cards. However, the high initial deployme …
- 光ファイバーアッテネータの世界市場予測This is the ElectroniCast worldwide market forecast of the consumption of component-level fiber optic attenuators in communication applications. The optical attenuators, which are covered in this study, are components used to control (reduce) the power level of an optical signal used in optical fiber communication networks. Fiber optic attenuators are an important part of the optical communication …
- Goodrich Petroleum Corporation社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Goodrich Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Goodrich Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is a …
- 衛星サービスの世界市場：消費者サービス、固定衛星サービス、モバイル衛星サービス、リモートセンシング、宇宙飛行管理サービスThe satellite services market accounted for $126.5 billion in 2018, and is anticipated to reach $144.5 billion by 2026, registering a CAGR of 2.2% from 2019 to 2026. The satellite services market is anticipated to grow during the forecast period owing to the rising demand for broadband connectivity services in APAC and LAMEA. Moreover, some of the countries in the Middle East and Africa have less …
- Enerjisa Enerji Uretim A.S.：発電所及び企業SWTO分析2015Enerjisa Enerji Uretim A.S. - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summar …
- 加入者データ管理市場（The Subscriber Data Management (SDM) Market: 2012 – 2016）Subscriber data is a principal asset held by network carriers. Subscriber Data Management (SDM) allows carriers to consolidate and manage their cross domain subscriber data encompassing access preferences, authentication, services, identities, location, and presence into unified data repositories. Besides enabling considerable OPEX reductions and allowing carriers to deliver more personalised serv …
